Savonix

About:

Savonix brings you the world’s first clinical, evidence-based, all-mobile digital assessment of cognitive and emotional function.

Website: http://www.savonix.com/

Twitter/X: savonixinc

Top Investors: Kickstart, Wavemaker Partners, StartUp Health, Fusion Fund, Wavemaker 360

Description:

Savonix provides a valid and reliable measurement of cognitive function mapped to real world outcomes in domains like cognitive flexibility and on road performance in aging populations. Their customers include doctors, researchers, Fortune 50 insurance, and governments. Their platform provides users with easy to use and accessible tests of their brain function in multiple domains from memory to implicit learning that they can complete on a smartphone or tablet – guided and reported on by a virtual clinician. This information can in turn be used to understand risk for dementia and other brain disorders, as well as drive precision medicine in treatment planning and diagnosis. Unique to Savonix is their 3D game platform for testing that drives meta-data which has already resulted in the ability to report on the novel cognitive domain of Implicit Learning without adding a test but deriving it from passive in app performance in gold standard measures. Savonix is the only widely available mobile-ready digital cognitive test for early detection of cognitive change that is backed by decades of research into cognitive testing. They didn’t invent the wheel, they made it affordable, accessible, actionable and scalable.

Total Funding Amount:

$16.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2015-01-01

Founders:

Mylea Charvat, PhD

Number of Employees:

11-50

Last Funding Date:

2019-03-30

IPO Status:

Private

© 2024 MyAiNote.com